Later, results in a phase I study by Deswal on NYH class III heart failure patients using etanercept—a soluble TNFα receptor antagonist—showed borderline significant improvements in ejection fraction after a 6 minute walk test and reduced serum levels of TNFα [ 24 ].
← all excerpts
Cytokine Pathways in Cardiac Dysfunction following Burn Injury and Changes in Genome Expression.
1
—
—